• Phlebitis is one of the most frequent complications related to short peripheral catheters (SPC).
Introduction
In modern healthcare, about half of the patients admitted to hospitals receive intravenous (i.v.) therapy on a daily basis [1] . Short peripheral catheters (SPCs) are the most common type of intravenous access device in both hospitals and paramedic services. The cannulation is indicated for short-term use, up to 72-96 h [2] , mainly for administration of i.v. fluids, drugs, parenteral nutrition and blood products [3] . An SPC is inserted through the skin into a peripheral vein, commonly in the cephalic or basilic veins of the lower arm, or the dorsal venous arch located on the back of the hand [4] . Other than the cannula's polymeric formulation, the invasive segment of SPCs has not changed in the last decades: an elongated polymeric cannula that is mounted on a metal needle, which is removed and discarded after insertion of the cannula into the peripheral vein. The size of the SPC, typically indicated in Gauge (G), ranges from 26 to 14 G, which corresponds to a caliber of~0.6-2.2 mm and length of 19-50 mm, respectively.
Severe complications (e.g. blood stream infection) are rarely associated with the use of SPCs [5] . Nevertheless, local complications (i.e. at catheter insertion site) can be very common and may lead to increased morbidity, delayed treatment and prolonged hospitalization [6] [7] [8] [9] [10] [11] . Short peripheral catheter thrombophlebitis (SPCT) is amongst the most common complications [7, [11] [12] [13] . SPCT is a local, non-infectious, inflammation of the vein wall and can be associated with thrombus build-up in the vein lumen. It manifests as pain and visible symptoms, such as erythema, edema, tenderness, warmth and a palpable cord. The prevalence of SPCT varies widely between 2.5% and 80% of patients receiving i.v. treatment [14] [15] [16] [17] [18] . This remarkable variation is in part influenced by different study designs, patient selections and follow-up times, different SPC materials and the use of an individual rather than universally valid definition of SPCT [9, 19] . Despite the high prevalence of SPCT, the etiology and pathogenesis are not completely understood. Several risk factors have been associated with increased rates of SPCT, mainly related to chemical (infusate composition) [20] [21] [22] [23] [24] , mechanical or bacterial (infectious SPCT) [25, 26] issues, or the patient's vulnerability [1, [27] [28] [29] .
Mechanical SPCT is caused by physical trauma to the endothelial layer of the vein wall. Risk factors associated with mechanical SPCT are the catheter's size (bore size), the composition of the cannula material (affecting stiffness), the anatomic size of cannulation, the insertion technique and deficient fixation and dressings [8, 11, 30] . Although these risk factors are based on retrospective statistical analyses, our research group has investigated the biomechanical aspects of SPCT directly using in vitro [31, 32] , in vivo [33] and in silico [31, 34] biomedical engineering methodologies. Our findings revealed that phenotypes of endothelial cells become proinflammatory and procoagulatory as a function of the physical pressure load exerted on them by the catheter, and that disturbed blood flow in the region of the active endothelial cells promotes thrombus growth and local inflammation even further. Recent investigation by Murayama et al. of 154 patients supports our findings, indicating a strong correlation between phlebitis and contact of the catheter tip with the vein wall [35, 36] . These findings explain in part the etiology and pathogenesis of mechanical SPCT and were used by our group to develop a new SPC device that would eliminate the mechanical irritation to the endothelial cells, with the aim of minimizing the progression rate of SPCT, and potentially extending the catheter dwell time in situ beyond the currently recommended 3 days. Interestingly, and to the best of our knowledge, the evolution of SPC devices to date has been focused on the material properties and chemistry of the cannula, whereas no design change was addressed for the invasive part of the cannula.
In the present study we introduce a novel very short peripheral catheter (VSPC) device, designed to minimize mechanical SPCT, and evaluate its performance in an in vivo swine model in comparison with a commercial SPC.
Methods

VSPC prototyping
The VSPC device is presented in Fig. 1 . The guiding considerations for the new catheter design were (i) the invasive part of the cannula should avoid contact with the vein's opposite wall and (ii) disturbances to the blood flow should be minimized. In addition, to make it feasible for such a catheter to enter into clinical use it must also be (iii) competitive in price and (iv) operated similarly to commercially available SPCs. The design modifications in the VSPC include significant shortening of the invasive section of the cannula to avoid bending the catheter against the opposite wall of the vein (Fig. 1) . Moreover, a protrusion was added a few millimeters away from the catheter tip as an anchoring element, to prevent the short cannula from spontaneously slipping outside of the vein. The protrusion was shaped with a leading-edge angle sharper than the trailing edge to minimize resistance during insertion. The prototyping process is described in detail in Data S1 and Figs S1-S3.
The VSPC was prototyped for this study by modifying a commercial SPC device (20G BD Insyte TM , Becton Dickinson, Franklin Lakes, NJ, USA), and similar, unmodified, SPC units were considered as the control reference group. This approach was chosen to isolate the geometrical design of the catheter as the test parameter and eliminate any biochemical differences between the catheter groups.
Study design
Fourteen female swine (Landrace breed, Lahav CRO, Lahav, Israel) (female animals were used because they are much less aggressive than male animals when being handled), weighing 60-65 kg, were used in this study. The animals were housed at the preclinical research unit of the Assaf Harofeh Medical Center (Be'er Ya'akov, Israel), which is accredited as working in compliance with the OECD-GLP (Good Laboratory Practice) principles. All procedures reported herein were approved by the Helsinki Committee of the Assaf Harofeh Medical Center and all efforts were made to alleviate suffering of the animals. The swine arrived at the habitat compound at least 1 week prior to the experimental procedures to ensure smooth acclimation. Their ears (n = 28) were then randomly assigned to either the VSPC (n = 12) or the commercial SPC (n = 12), and four ears (n = 4) were used as naive controls. Eleven pigs had both ears catheterized (one ear with a VSPC and the other with an SPC). In the other two pigs only one ear was catheterized and the other used as control, and the ears of the last pig were both used as controls.
On the first day of the experiment, the swine were premedicated intramuscularly with an 11-mL cocktail containing 10 mL ketamine (100 mg mL À1 ) and 1 mL xylazine (100 mg mL
À1
), then anesthetized with isoflurane (2%) and their ears shaved and sterilized. The catheters were then inserted by a certified veterinarian into the lateral aspect of the marginal ear vein (one catheter per vein). Veins were 3.0-3.3 mm in diameter, yielding a catheter-to-vein ratio of 3.7-4.1. Veins were flushed with heparinized saline, sealed with luer lock, glued to the surrounding tissue using designated tissue adhesive (Hystoacryl, B, Braun Medical, Bethlehem, PA, USA), and finally secured with transparent film dressing (Tegaderm TM , 3M, St. Paul, MN, USA) and a full roll of gauze and leucoplast (Fig. 2) . All catheters were inserted by the same veterinarian. The swine returned to their recovery runs with free access to water and a strict diet plan. For the following 12 consecutive days the cannulated ear veins were evaluated for the development and severity of SPCT using magnetic resonance imaging (MRI): on day 4 (96 h), referred as time-point 1 (TP-1), and on day 12 immediately before animal sacrifice (TP-2). Prior to each MRI scan, the swine were sedated (as described above), and at the end of the second scan (day 12) the swine were euthanized (100 mL KCL 15%) and the catheter sites (along with the catheters) were harvested and fixed in 10% neutral-buffered formalin solution (Santa Cruz Biotechnology Inc., Dallas, TX, USA) for blinded histopathology analysis. It is important to note that this 12-day period does not reflect intended use in a clinical setting. The study was chosen to last 12 days to allow SPCT to be developed, and to assure enough sensitivity to measure the SPCT development profile, for comparison between the catheter groups.
Verification of VSPC positioning
After positioning of catheters, a Doppler ultrasound (US) was used to observe the position of the indwelling catheters within the vein, in order to verify that it met the manufacturing demands and that mechanical interaction with the vein's opposite wall was indeed avoided. Echo Doppler was then measured for assessing blood flow within the cannulated vein, and for indication of a possible disorder resulting from the presence of the VSPC or SPC. US examination was performed by a certified veterinarian sonographer, immediately following the insertion of the catheters and just before dressing of the catheter site, using a M9 US machine (Mindray, Shenzhen, China) with L14-6Ns linear transducer (3.5-16 MHz), field of view (FOV) of 38 mm and US gel (Aquasonic 100, Parker Laboratories Inc., Fairfield, NJ, USA). In addition, gel pads (Sonar Pad, Nippon Bxi Inc., Tokyo, Japan) were used to avoid vein disfiguration by the transducer. Because this step was only a verification of the positioning of the catheters within the vein, only six of the animals were scanned (selected randomly).
MRI acquisition
MRI was performed in a 3 Tesla scanner (Magnetom Skyra, Siemens, Germany) using a 20-channel head coil. The animal was placed in a prone position and its head was tilted to one side at a time in order to focus on one 
MRI analysis
Quantitative T 2 maps: image analysis was performed using MATLAB Ò (MathWorks, Matick, MA, USA) as previously described [33] . Briefly, a T 2 map was calculated in a voxel by voxel manner with mono-exponential fit using a least squares non-linear model with the following equation:
where S(t) is the measured MR signal for each TE, and S 0 and T 2 are the fitted parameters. The goodness of fit (GOF) was evaluated using R 2 . Voxels with GOF smaller than 0.9 were excluded from the analysis.
The MRI analysis workflow, including determination of regions of interest (ROI), is depicted in Fig. 3 . The T 1 FS post-GD injection and T 2 maps were cropped to include only the area of the vein. The tissue surrounding the vein was defined using an ellipse-shaped region, which includes 90-130 voxels per slice (i.e. small ROI). Only slices in which the vein could be visualized were included in the analysis, resulting in a total of 8-12 slices per ear. A wider ROI (i.e. large ROI) was then defined to include a region of~200-mm length surrounding the vein and above the ear's tendon tissue. The small ROI was utilized to find a threshold that distinguished between healthy (normal) and non-healthy (inflammatory) pixels by applying a receiver operating characteristic (ROC) analysis.
This threshold was then used to classify all pixels within the large ROI and calculate the percentage of inflammation/edema in each ear. The percentage of non-healthy voxels in a slice was calculated as the number of voxels above the threshold divided by the total number of voxels in the large ROI.
Statistical analysis
Statistical analysis included two steps: (i) model validation on the small ROI and (ii) infection/edema rate estimation on the large ROI. For the model validation, the T 1 and T 2 intensity readings were compared between the three treatment groups: control (n = 4), SPC (n = 8) and VSPC (n = 8). Because of deviation from normality, comparisons were performed using the non-parametric Kruskal Wallis test followed by the Dunn's post-hoc test. Then, ROC analysis was applied to determine a threshold that can distinguish between readings from control and treated samples. The area under the curve (AUC) was calculated for each sample at each time-point with 95% confidence interval, and the threshold that best distinguished between SPC and control at TP-1 was selected. To enable generalization, an integrated threshold was selected as the average threshold of all samples at TP-1. For estimation of inflammation/edema rates, in order to compare the percentage of the infected area, the integrated threshold was used. All intensities below the threshold were defined as normal, whereas intensities above the threshold were defined as edema/inflammation. The calculated rate was compared using the Fisher exact test and the P-value was defined as two-sided P < 0.05. Analyses were carried out using SPSS 24.01 (IBM, Armonk, NY, USA).
Histopathology
The tissues were routinely processed, embedded in paraffin, sectioned at 5-lm thickness and stained with hematoxylin and eosin (H&E). In the catheterized samples (SPC and VSPC), the first 30 mm from the venipuncture were trimmed to 10 blocks of equal width, each approximately 3 mm. From each trimmed block, three paraffinembedded sections were taken, at level 0 (edge of the sample) and at distances of 1.0 and 2.0 mm from the first sectioned site. The samples were trimmed perpendicular to the vein. Histopathological evaluation was carried out in a blinded (masked) manner [37] . The biological response parameters were evaluated by a board-certified pathologist using semiquantitative grading of five grades (0-4), taking into consideration the severity and/or extension of the response (0 = none, 1 = slight, 2 = mild, 3 = moderate, 4 = severe), based on Shackelford et al. [38] . The evaluated parameters were based on Berridge et al. [39] : blood vessel inflammation, thrombus formation, exfoliation of endothelium, intimal edema, intimal necrosis and hemorrhage. For statistical analysis (twogroup comparisons), multiple Student's t-tests were used. Severity of the observed lesions was generally based on the criteria published in the Society of Toxicologic Pathology (STP) position paper [40] .
Results
Ten out of 14 swine managed to keep both catheters in place until the end of the last experiment day (day 12). In the other four, one or both catheters were prematurely pulled out of the vein and thus these animals could not be included in the experiment. The control group consisted of two animals, a total of four ears. For the eight animals that completed the entire course of the experiment with both catheters in place, all catheters remained intact without any signs of cuts or tears. All protrusions kept the original shape and did not deform (confirmed following catheter removal).
Verification of VSPC positioning
US imaging was performed in six out of 12 animals on day 1 and confirmed that the VSPC conformation within the vein was meeting our design requirements (Fig. 4) . The VSPC cannula avoided contact with the opposite vein wall. In contrast, the commercial SPC had constant contact with the wall. Based on the US Doppler images, an improvement in blood flow could be also observed with the VSPC (Fig. 4) (as it allowed open flow regions in the surrounding of the cannula). However, this could not be quantified because of limitations in the quality of the US images.
MRI analysis
Evaluation of phlebitis severity was performed using quantitative T 2 maps for edema and T 1 enhancement for inflammation. Representative T 1 images are presented in Fig. 5 , which visually demonstrate lower inflammation rates in SPC vs. VSPC at two time-points.
Box plots of T 1 intensities (a.u.) and T 2 values (ms) within the small ROI encompassing the penetrated vein per animal are presented in Fig. 6 . The values are also detailed in Table S1 . Post-hoc comparison tests (Dunn's) were statistically significant (P < 0.001) for all the comparisons and showed consistent hierarchy between the three groups for seven out of eight animals: SPC values were significantly higher than VSPC values, and VSPC values were higher than control. The only exception was the T 2 parameter for animal #1 at TP-1, where the differences between SPC and VSPC were not significant. Differences between TP-1 and TP-2 readings were not found to be statistically significant in most of the comparisons, for both T 1 and T 2 . However, the average intensity of T 1 at TP-2 was higher than the average at TP-1 for all animals except animal #3 (Fig. 6) .
All the AUC values (for the discrimination ability between SPC or VSPC vs. control) for T 1 and T 2 were statistically significant (lower limit > 0.5) and, as expected, all cases (except animal #1 at TP-1 for T 2 ) demonstrated higher discriminative ability (higher AUC) between the SPC and control than VSPC and control, suggesting that VSPC induced lower inflammation and edema grades compared with SPCs. The average thresholds for the calculation of edema (T 2 ) In the sagittal view images vein lumen is marked with a filled red arrow, the filled yellow arrow points to the lower catheter wall and the dashed line arrow to the upper wall. In the longitudinal images, the dashed red line represents the upper and lower vein walls, whereas in panel E the VSPC protrusion is marked with a yellow dashed line. It can be clearly seen that the lower catheter wall is located within the lumen and does not contact the opposite vein wall (in panel F, the distance between the lowest catheter position and the lower vein wall is marked with two green cursors). C1, D, C2 and H describe the flow velocity contours within the VSPC cannulated vein. In C1 the flow is shown on the catheter sides and in C2 and H it appears beneath the VSPC's lower wall. B, D and G images represent the commercial catheter, in which the flow only appears on the sides of the catheter (D) and the lower catheter wall constantly contacts the vein wall (B and G). VSPC, very short peripheral catheter.
and inflammation (T 1 ) in the large ROI were 46.3 and 259.7 ms, respectively. These average thresholds were calculated at TP-1 and were used to classify each pixel in the large ROI to either inflammatory or 'normal' pixels. Figure 7 summarizes the rate of inflamed pixels for each animal per T 1 and T 2 . In all animals, the VSPC demonstrated significantly lower inflammation (T 1 ) and edema (T 2 ) rates compared with the SPC, both at TP-1 and TP-2 (P < 0.001 and edema in the catheter groups, no visual signs for common SPCT markers were observed in any animal at any time-point during the experiment.
Histopathological evaluation
A graphical presentation of the mean severity data of the histopathological findings observed in each animal is summarized in Fig. 8 , and representative histological sections are presented in Fig. S4 . The histopathological evaluation indicated that all observed lesions in the SPC samples were adverse, reflecting a relatively chronic process that was developing following previous intravascular traumatic injury. The histomorphological data indicated that the vascular integrity was lower in the SPC-derived samples when compared with the VSPC. A singular parameter of 'intimal edema' was slightly higher in the VSPC group when compared with the SPC samples. However, because the edema was not accompanied by any other changes to the vein wall (i.e. hemorrhage, necrosis, inflammation, intimal proliferation or thrombus formation), the increased grade of intimal edema can be considered as an insignificant adverse event [40] . In all other evaluated parameters, the mean severity was lower for the VSPC group compared with the SPC-derived samples. Thrombus formation was observed in most of the SPC samples. The thrombi were composed of organizing fibrotic tissue, occluding the vascular lumen by varying degrees. The inflammatory reaction was composed of mixed mononuclear cells with fibroblastic proliferation and collagen deposition. All changes observed in the control samples were graded as being of minor severity and received the lowest average score for all parameters.
Discussion
In the present study, we introduced a novel SPC design and demonstrated proof of concept for reduction of catheter-related phlebitis in a swine model in vivo. The novel VSPC was designed based on biomechanical criteria for minimizing the mechanical irritation of the endothelial cells lining the vein wall. We compared the VSPC design with a commercial SPC that is common in the clinical setting, while focusing on mechanical SPCT. One of the design criteria of the VSPC was to maintain its operation in a similar way to clinically used SPCs. The veterinarians reported no differences in the required insertion skills/techniques between the VSPC and SPC, with no special training required. However, the protrusion in the VSPC sometimes added resistance to the insertion procedure and required a gentle push of the catheter into the vein. It is important to note that in the current study we shortened the non-invasive part of the cannula as much as possible, to make it more difficult for the swine to remove it. Basically, we could keep the length of the non-invasive part similar to commercial catheters and secure it to the surrounding ear tissue; however, this is an unpractical approach with swine as they were constantly trying to remove the catheters. Almost 80% of pixels indicated inflammation and edema in the SPC group, as revealed by the MRI analysis. In contrast, only~40% of pixels of the VSPC veins were inflamed or edematous. This indicates that the VSPC device was successful in reducing the severity of phlebitis and confirms that biomechanical factors play a role in SPCT. The US scans confirmed that the tip of the VSPC was not in contact with the opposite wall of the vein, in comparison with the commercial SPC device. The disturbed blood flow patterns of the commercial SPC are in agreement with our previous computational analyses [31] , on which the VSPC design was based. Nevertheless, it should be noted that the resolution of US imaging was not sufficient enough for performing quantitative analysis.
The histopathologic evaluation was performed after animal sacrifice and confirmed the findings from the MRI analysis, revealing a significant difference between the SPC and VSPC. It should be noted that although the SPC-implanted veins were characterized by a significantly higher pathological score, the overall score for both catheters did not cross, in most cases, grade 2 and no severe response of the biological parameters was observed.
The fact that both the histopathological and visual inspection scores were relatively low indicates the high sensitivity of the MRI method used here for quantification of SPCT.
VSPC-catheterized veins were not expected to experience worsening of inflammation and/or edema because it was assumed that the mechanical interaction was avoided. In spite of significant differences found in the MRI analysis between the SPC and VSPC, no such differences were found between the two time-points, either for the SPC or for the VSPC. This observation was supported to some extent by the histopathological evaluation, which indicated that the salient feature was the progressive healing and fibrotic process, highlighted by relatively higher scores of thrombus formation seen in the SPC samples. This chronic healing process might have developed in parallel to the inflammatory processes that were still occurring as a result of the prolonged interaction with the vein wall. Altogether, this could be an explanatory model for the insignificant changes between TP-1 and TP-2. A minor trend was observed in the T 1 relaxation time, in which the average intensity values for both catheters were higher at TP-2 in seven out of eight animals; however, this trend was not statistically significant. It is important to note in this regard that although the position of the VSPC within the vein was validated several times, the veins behave as a collapsible tube and it is possible that some catheter-vein interactions occurred during the indwelling period and also activated inflammation processes to a certain extent [32] .
The swine ear comprises various tissue components (i.e. fat, tendon, cartilage, connective tissue and blood vessels), with each having its own characteristic T 1 /T 2 relaxation times. This made the process of threshold determination, which aimed to quantitate the rate of inflammation/edema, much more challenging. Therefore, we first chose to consider a small region encompassing only the vein lumen: a small ROI, which was assumed to be composed, under normal healthy conditions, of similar 'tissue pixels' with similar characteristic T 1 and T 2 . In such a way, determination of a more reliable threshold value was guaranteed. Unsurprisingly, the catheterized veins yielded higher discrimination ability values (higher AUC value). That is to say, the values of T 1 and T 2 within the small ROI were higher, and therefore finding an optimal threshold that differs between inflammatory/edematous pixels and normal ones (sensitivity and specificity close to 1) was easier. Overall, the threshold value that was found in the SPC group was the one chosen to classify tissue pixels in the large ROI. Although the small ROI was about the size of 100 pixels, the size range of the large ROI varied across different ears and across scanned slices of the same ear (a few hundred to a few thousand pixels). The main reason for that was the anatomical variability between either consecutive slices or different ears, which affected the scanned size of the vein's surroundings and its number of pixels. Several protective elements were used to secure the catheters to the swine ear to ensure that the catheter remained in situ throughout the experiment. Nevertheless, four animals managed to remove all the bandages and pull out one or both catheters. In all of these cases the incident occurred in the first 48 hours after the catheter insertion. It should be noted in this regard that both the VSPC and SPC were pulled out by the animals and were found outside the vein with no evidence of preference for either of the catheters. Visual inspection of these catheters, especially of the novel VSPC, revealed an intact structure with no signs of cuts, kinking or other defects in the cannula or protrusion.
Nowadays, the main focus of the leading catheter manufacturers is to improve the material from which these catheters are made by trying to formulate polymers with enhanced biocompatibility and better bacterial resistibility and which are more comfortable for the patients (produce less pain). Further efforts are being made to enhance the safety mechanism of the catheter's needle in order to prevent possible needle-stick injuries and contamination of patients and medical staff. To the best of our knowledge, the VSPC is the first attempt to design catheters with substantial geometrical modifications that aim to avoid catheter-vein biomechanical interactions, and thus minimize the development of mechanical phlebitis. The results of the swine trial showed clear outcomes of reduction of the inflammation and edema rates by almost half when using the VSPC, compared with the commercially available SPC. Based on the promising in vivo results, we believe that our biomechanical design approach has the potential to reduce thrombophlebitis development rates associated with short peripheral catheters. This may have implications for extending catheters' dwell time in situ and for reduction of associated economic burdens.
There are several limitations associated with the study design that need to be considered. First, the catheters were tested in a swine model, which has a different physiology to humans (e.g. vascular function, coagulation, platelet biology and sterile inflammatory responses). Even though the catheters were selected to have a catheter-vein size ratio similar to that used in the clinical setting, the physiological differences between the species have an effect on the overall rate of development of phlebitis. Evidently, visual SPCT symptoms were absent, or at most very minimal, after 12 days of cannulation, whereas in humans they appear on average after approximately 3 days. For this reason, the conventional clinical measurement of visual scoring was not utilized, as it was not sensitive enough. This was addressed in this study by using a more sensitive measurement method (MRI), which was confirmed by reference-standard histopathology analysis. Despite the overall low grades of phlebitis, the MRI was able to clearly differentiate between the catheters in terms of severity of inflammation and edema. Future studies should demonstrate a similar comparison; however, under higher grades of phlebitis. Another limitation that is also related to the animal model is the extra securement of the catheters to the skin. This was a necessary precaution for preventing the swine from actively removing the catheters. This securement method minimized relative motion between the catheter and the skin; however, it did not eliminate relative motion between the cannula and the vein, and therefore we believe that its effect on the results was minimal. Second, this study was limited to superficial veins. Future studies should include anatomical variations of the vasculature, including deeper veins or the presence of thicker subdermal fat tissue. In that case, the 'non-invasive' section of the cannula (from the protrusion to the hub) may be extended to fit the required length, while keeping the 'invasive' section of the cannula (protrusion to tip) short, as was presented herein. 
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Data S1. VSPC prototype manufacturing. Fig. S1 . General view of the apparatus for VSPC manufacture. The apparatus is composed of DelrinÒ made mounts for holding the catheter and the needle aligned, portable heating unit connected to a temperature controller and a timer. Fig. S2 . Bump manufacture process. A needle having a bump-shaped wire at its tip (A) is introduced into a commercial SPC (BD Insyte TM ) (B). The wire is pulled back towards the catheter hub, forming a protrusion on the cannula surface (C). The heating unit is then placed underneath the protrusion and activated for 50 s (130°C), ensuring transition of the cannula material to a plastic state (D). The catheter is then released from the needle, ready for the next manufacturing step. Fig. S3 . Cannula shortening and reassembling. The catheter after protrusion manufacture (A) was shortened to 10 mm in length (B) and a metal cone tubing holder (C) was placed on the tip of a heating knob (D). The shortened cannula was then threaded on to the tubing holder while the heated brass tip softened the cannula and eased the threading process (E). (F) The final VSPC. Fig. S4 . Representative histological cross-sections of veins catheterized with SPC (A-C), VSPC (D-F) and control (G). Description of the pathological findings and the corresponding pathological score is presented at the top of each image. Table S1 . Summary of inflammation (A) and edema (B) rate for each animal. 'N' refers to the number of pixels within the large ROI, which have been classified according to the threshold found in the small ROI. P-value refers to the comparison between % of inflammatory/edematous pixels in SPC vs. VSPC per animal. Comparisons were performed using the Fisher exact test.
